Integumen acquired scientific data management specialist Rinocloud to develop its artificial intelligence platform earlier this year
PLC’s () wholly-owned subsidiary Rinocloud was recognised as “one to watch” in TechLeaders19 IT award, which highlights the most innovative projects in the Irish tech sector.
Earlier this year, , the developer of the Labskin clinical research technology, acquired scientific data management specialist Rinocloud to develop its artificial intelligence platform.
“We are so honoured to have received this IT Leadership award in recognition of the Rinocloud team's creation of a disruptive drug discovery process for skin diseases such as psoriasis, eczema, acne and dandruff,” said Fin Murray, managing director of Rinocloud.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...
FOR OUR FULL DISCLAIMER CLICK HERE